Cargando…

A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases

Background: The etiology of autoimmune rheumatic diseases is unknown. Endothelial dysfunction and premature atherosclerosis are commonly seen in these patients. Atherosclerosis is considered one of the main causes of cardiovascular diseases. Hypertension is considered the most important traditional...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahdy, Ahmed, Stradner, Martin, Roessler, Andreas, Brix, Bianca, Lackner, Angelika, Salon, Adam, Goswami, Nandu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467719/
https://www.ncbi.nlm.nih.gov/pubmed/34575178
http://dx.doi.org/10.3390/jcm10184067
_version_ 1784573470653284352
author Mahdy, Ahmed
Stradner, Martin
Roessler, Andreas
Brix, Bianca
Lackner, Angelika
Salon, Adam
Goswami, Nandu
author_facet Mahdy, Ahmed
Stradner, Martin
Roessler, Andreas
Brix, Bianca
Lackner, Angelika
Salon, Adam
Goswami, Nandu
author_sort Mahdy, Ahmed
collection PubMed
description Background: The etiology of autoimmune rheumatic diseases is unknown. Endothelial dysfunction and premature atherosclerosis are commonly seen in these patients. Atherosclerosis is considered one of the main causes of cardiovascular diseases. Hypertension is considered the most important traditional cardiovascular risk. This case-control study aimed to investigate the relationship between autoimmune diseases and cardiovascular risk. Methods: This study was carried out in patients with rheumatoid arthritis, RA (n = 10), primary Sjögren syndrome, PSS (n = 10), and healthy controls (n = 10). Mean blood pressure (MBP), systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse wave velocity (PWV, an indicator of arterial stiffness) were assessed via a Vicorder device. Asymmetric dimethylarginine (ADMA) was measured via ELISA. Retinal photos were taken via a CR-2 retinal camera, and retinal microvasculature analysis was carried out. T-tests were conducted to compare the disease and control groups. ANOVA and ANOVA—ANCOVA were also used for the correction of covariates. Results: A high prevalence of hypertension was seen in RA (80% of cases) and PSS (40% of cases) compared to controls (only 20% of cases). Significant changes were seen in MBP (RA 101 ± 11 mmHg; PSS 93 ± 10 mm Hg vs. controls 88 ± 7 mmHg, p = 0.010), SBP (148 ± 16 mmHg in RA vs. 135 ± 16 mmHg in PSS vs. 128 ± 11 mmHg in control group; p = 0.007), DBP (77 ± 8 mmHg in RA, 72 ± 8 mmHg in PSS vs. 67 ± 6 mmHg in control; p = 0.010 in RA compared to the controls). Patients with PSS showed no significant difference as compared to controls (MBP: p = 0.240, SBP: p = 0.340, DBP: p = 0.190). Increased plasma ADMA was seen in RA (0.45 ± 0.069 ng/mL) and PSS (0.43 ± 0.060 ng/mL) patients as compared to controls (0.38 ± 0.059 ng/mL). ADMA in RA vs. control was statistically significant (p = 0.022). However, no differences were seen in ADMA in PSS vs. controls. PWV and retinal microvasculature did not differ across the three groups. Conclusions: The prevalence of hypertension in our cohort was very high. Similarly, signs of endothelial dysfunction were seen in autoimmune rheumatic diseases. As hypertension and endothelial dysfunction are important contributing risk factors for cardiovascular diseases, the association of hypertension and endothelial dysfunction should be monitored closely in autoimmune diseases.
format Online
Article
Text
id pubmed-8467719
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84677192021-09-27 A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases Mahdy, Ahmed Stradner, Martin Roessler, Andreas Brix, Bianca Lackner, Angelika Salon, Adam Goswami, Nandu J Clin Med Article Background: The etiology of autoimmune rheumatic diseases is unknown. Endothelial dysfunction and premature atherosclerosis are commonly seen in these patients. Atherosclerosis is considered one of the main causes of cardiovascular diseases. Hypertension is considered the most important traditional cardiovascular risk. This case-control study aimed to investigate the relationship between autoimmune diseases and cardiovascular risk. Methods: This study was carried out in patients with rheumatoid arthritis, RA (n = 10), primary Sjögren syndrome, PSS (n = 10), and healthy controls (n = 10). Mean blood pressure (MBP), systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse wave velocity (PWV, an indicator of arterial stiffness) were assessed via a Vicorder device. Asymmetric dimethylarginine (ADMA) was measured via ELISA. Retinal photos were taken via a CR-2 retinal camera, and retinal microvasculature analysis was carried out. T-tests were conducted to compare the disease and control groups. ANOVA and ANOVA—ANCOVA were also used for the correction of covariates. Results: A high prevalence of hypertension was seen in RA (80% of cases) and PSS (40% of cases) compared to controls (only 20% of cases). Significant changes were seen in MBP (RA 101 ± 11 mmHg; PSS 93 ± 10 mm Hg vs. controls 88 ± 7 mmHg, p = 0.010), SBP (148 ± 16 mmHg in RA vs. 135 ± 16 mmHg in PSS vs. 128 ± 11 mmHg in control group; p = 0.007), DBP (77 ± 8 mmHg in RA, 72 ± 8 mmHg in PSS vs. 67 ± 6 mmHg in control; p = 0.010 in RA compared to the controls). Patients with PSS showed no significant difference as compared to controls (MBP: p = 0.240, SBP: p = 0.340, DBP: p = 0.190). Increased plasma ADMA was seen in RA (0.45 ± 0.069 ng/mL) and PSS (0.43 ± 0.060 ng/mL) patients as compared to controls (0.38 ± 0.059 ng/mL). ADMA in RA vs. control was statistically significant (p = 0.022). However, no differences were seen in ADMA in PSS vs. controls. PWV and retinal microvasculature did not differ across the three groups. Conclusions: The prevalence of hypertension in our cohort was very high. Similarly, signs of endothelial dysfunction were seen in autoimmune rheumatic diseases. As hypertension and endothelial dysfunction are important contributing risk factors for cardiovascular diseases, the association of hypertension and endothelial dysfunction should be monitored closely in autoimmune diseases. MDPI 2021-09-09 /pmc/articles/PMC8467719/ /pubmed/34575178 http://dx.doi.org/10.3390/jcm10184067 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mahdy, Ahmed
Stradner, Martin
Roessler, Andreas
Brix, Bianca
Lackner, Angelika
Salon, Adam
Goswami, Nandu
A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases
title A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases
title_full A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases
title_fullStr A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases
title_full_unstemmed A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases
title_short A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases
title_sort pilot study: hypertension, endothelial dysfunction and retinal microvasculature in rheumatic autoimmune diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467719/
https://www.ncbi.nlm.nih.gov/pubmed/34575178
http://dx.doi.org/10.3390/jcm10184067
work_keys_str_mv AT mahdyahmed apilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT stradnermartin apilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT roesslerandreas apilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT brixbianca apilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT lacknerangelika apilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT salonadam apilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT goswaminandu apilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT mahdyahmed pilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT stradnermartin pilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT roesslerandreas pilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT brixbianca pilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT lacknerangelika pilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT salonadam pilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases
AT goswaminandu pilotstudyhypertensionendothelialdysfunctionandretinalmicrovasculatureinrheumaticautoimmunediseases